1. Home
  2. HOVR vs ALXO Comparison

HOVR vs ALXO Comparison

Compare HOVR & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOVR
  • ALXO
  • Stock Information
  • Founded
  • HOVR 2013
  • ALXO 2015
  • Country
  • HOVR Canada
  • ALXO United States
  • Employees
  • HOVR N/A
  • ALXO N/A
  • Industry
  • HOVR Blank Checks
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HOVR Finance
  • ALXO Health Care
  • Exchange
  • HOVR Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • HOVR 103.1M
  • ALXO 102.3M
  • IPO Year
  • HOVR N/A
  • ALXO 2020
  • Fundamental
  • Price
  • HOVR $3.38
  • ALXO $1.92
  • Analyst Decision
  • HOVR Strong Buy
  • ALXO Strong Buy
  • Analyst Count
  • HOVR 1
  • ALXO 6
  • Target Price
  • HOVR $2.00
  • ALXO $3.30
  • AVG Volume (30 Days)
  • HOVR 1.6M
  • ALXO 761.3K
  • Earning Date
  • HOVR 10-15-2025
  • ALXO 11-06-2025
  • Dividend Yield
  • HOVR N/A
  • ALXO N/A
  • EPS Growth
  • HOVR N/A
  • ALXO N/A
  • EPS
  • HOVR 0.12
  • ALXO N/A
  • Revenue
  • HOVR N/A
  • ALXO N/A
  • Revenue This Year
  • HOVR N/A
  • ALXO N/A
  • Revenue Next Year
  • HOVR N/A
  • ALXO N/A
  • P/E Ratio
  • HOVR $27.43
  • ALXO N/A
  • Revenue Growth
  • HOVR N/A
  • ALXO N/A
  • 52 Week Low
  • HOVR $0.25
  • ALXO $0.40
  • 52 Week High
  • HOVR $3.51
  • ALXO $2.27
  • Technical
  • Relative Strength Index (RSI)
  • HOVR 75.37
  • ALXO 64.86
  • Support Level
  • HOVR $2.38
  • ALXO $1.83
  • Resistance Level
  • HOVR $2.87
  • ALXO $2.27
  • Average True Range (ATR)
  • HOVR 0.29
  • ALXO 0.20
  • MACD
  • HOVR 0.09
  • ALXO 0.01
  • Stochastic Oscillator
  • HOVR 94.21
  • ALXO 70.18

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: